Shilpa Medicare Limited (BOM:530549)
626.95
+5.85 (0.94%)
At close: Jul 10, 2026
Shilpa Medicare Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Shilpa Medicare stock has a consensus rating of "Buy" and an average price target of ₹603.00. The average 1-year stock price forecast is 3.82% lower than the current stock price, while the lowest is ₹481.00 (-23.28%) and the highest is ₹748.00 (+19.31%).
Price Target: ₹603.00 (-3.82%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Shilpa Medicare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Financial Forecast
Revenue This Year
18.00B
from 15.39B
Increased by 16.99%
Revenue Next Year
21.30B
from 18.00B
Increased by 18.33%
EPS This Year
13.30
from 11.93
Increased by 11.50%
EPS Next Year
18.50
from 13.30
Increased by 39.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 18.3B | ||
| Avg | 18.0B | ||
| Low | 17.5B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 18.8% | ||
| Avg | 17.0% | ||
| Low | 14.0% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 14.00 | ||
| Avg | 13.30 | ||
| Low | 12.70 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 17.4% | ||
| Avg | 11.5% | ||
| Low | 6.5% |